Shaking off the working week! What's on the agenda for the weekend? 📷 by KonstantinKolosov via… https://t.co/fSyxq53H6P
RT @placeitapp: Making a #YouTube banner for your channel is easy with Placeit's #bannermaker! Make your own in sec… https://t.co/0X22tX3wtm
Our Chief People Officer @MRidsdale16 joined @benjaminlaw and @raejohnston on @tsushow to discuss all things Cultu… https://t.co/uszxz0qicU
clinical Phase IIa pharmacodynamic data:
Both products have clinical Phase IIa pharmacodynamic data.
pharmacokinetic and pharmacodynamic data:
Monoclonal antibody, LycoMab, can be used as a vector to deliver and potentiate efficacy of pro-apoptotic lycopene to prostate cancer cells.
New class of molecules for prevention of restenosis of endovascular stents and vascular scaffolding.
Download LycoStent™ PDF